Stryker pays $15M fine in a DOJ Settlement after Unapproved OP-1 Clinical Study

  
 
 
 
Stryker Reaches Settlement with the U.S. Attorney's Office (press release)
Kalamazoo, Michigan - January 18, 2012 - Stryker Corporation (NYSE:SYK) announced today that Stryker Biotech has reached a settlement with the U.S. Attorney's Office for the District of Massachusetts.  As part of the settlement, Stryker has agreed to plead to one misdemeanor charge and pay a non-tax deductible fine of $15 million. As a result of this resolution, the Department of Justice has agreed to dismiss all thirteen felony charges against Stryker Biotech contained in a 2009 federal grand ju...


Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.